Page last updated: 2024-10-25

desipramine and Purpura, Thrombocytopenic, Idiopathic

desipramine has been researched along with Purpura, Thrombocytopenic, Idiopathic in 1 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Purpura, Thrombocytopenic, Idiopathic: Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lechin, F1
van der Dijs, B1
Orozco, B1
Jahn, E1
Rodriguez, S1
Baez, S1

Other Studies

1 other study available for desipramine and Purpura, Thrombocytopenic, Idiopathic

ArticleYear
Neuropharmacological treatment of refractory idiopathic thrombocytopenic purpura: roles of circulating catecholamines and serotonin.
    Thrombosis and haemostasis, 2004, Volume: 91, Issue:6

    Topics: Adult; Blood Platelets; Catecholamines; Child; Desipramine; Female; Hemorrhage; Humans; Male; Middle

2004